Preliminary Program

The 19th Annual Review of DDW and Other Key GI & Liver Meetings is available in the following format:

AGENDA

10:00 am	Welcome and Opening Remarks Speaker: Dr. Imran Rasul Details Imran Rasul, MD. HBSc., FRCP(C) Gastroenterology and Therapeutic Endoscopy Trillium Health Partners Staff Gastroenterology - Credit Valley Hospital Lecturer - University of Toronto Director - WGTA Endoscopy President - Ontario Association of Gastroenterology Dr. Imran Rasul completed his undergraduate training at the University of Toronto in 1992. He went on to complete his Medical Degree, Internal Medicine and Gastroenterology training at the University of Toronto. Further training in Advanced Therapeutic Endoscopy was completed at University of Toronto. He has been practicing in Mississauga at the Credit Valley Hospital for the past seven years. Dr. Rasul has an interest in Advanced Endoscopy and is Chair of the Endoscopy Unit at Credit Valley Hospital.
10:10 am	What’s New in Crohn’s and Ulcerative Colitis Speaker: Dr. Neeraj Narula Details Neeraj Narula, MD, MPH, FRCPC Assistant Professor of Medicine McMaster University Dr. Neeraj Narula is the Director of the IBD Clinic at McMaster University and a Staff Gastroenterologist at Hamilton Health Sciences. He completed the Present-Levison Advanced IBD fellowship at Mount Sinai Medical Centre in New York, NY, in 2015. He trained to be a Chartered Accountant at the University of Waterloo and has worked at Ernst & Young and KPMG. He subsequently attended medical school at the University of Alberta. He completed his internal medicine residency and gastroenterology fellowship training at McMaster University. He also obtained a Masters in Public Health at Harvard T. H. Chan School of Public Health. His research interests are predominantly in clinical epidemiology, nutrition, and pharmaceutical trials in IBD. Presentation Overview This presentation will review gastrointestinal pathologies which may benefit from treatment with fecal microbiota transplantation.
10:30 am	IBD Treatment During COVID-19 Speaker: Dr. Adam Weizman Details Adam V. Weizman, MD, MSc, FRCP(C) Division of Gastroenterology Mount Sinai Hospital Associate Professor of Medicine University of Toronto Dr. Weizman is a gastroenterologist at Mount Sinai Hospital in Toronto, Ontario and an Assistant Professor of Medicine at the University of Toronto. He received his medical degree from the University of Manitoba and subsequently did a Residency in Internal Medicine and Fellowship in Gastroenterology at the University of Toronto. He completed the Advanced Fellowship in Inflammatory Bowel Diseases at Cedars-Sinai Medical Center in Los Angeles, California and a Master's degree (MSc) in Quality Improvement and Patient Safety from the Institute of Health Policy, Evaluation, and Management at the University of Toronto. His research interests include healthcare quality and health outcomes, with a focus on inflammatory bowel disease (IBD). Dr. Weizman is the Medical Director of the Inflammatory Bowel Diseases Centre at Mount Sinai Hospital and Head of Quality and Patient Safety for the division of gastroenterology at Mount Sinai Hospital and the University Health Network.
10:50 am	Panel Discussion Moderator: Dr. Michael Gould Details Michael Gould, MD, FRCP(C) Assistant Professor, University of Toronto President and Medical Director, Vaughan Endoscopy Clinic Past President, Ontario Association of Gastroenterology Dr. Michael Gould is the President and Medical Director of the Vaughan Endoscopy Clinic. He is Vice President and a partner in the Toronto Digestive Disease Associates (TDDA) clinical research group, which has participated in many GI clinical research trials. He is the interim Endoscopy Director at William Osler Health System. Dr. Gould is a former Chief of Medicine of the William Osler Health System. He is a Past President and a founding member of the Ontario Association of Gastroenterology, and currently sits on the its Board of Directors. He is a board member of the Israel Cancer Research Fund. He was the CCO Endoscopy Lead from 2011- 2014, and helped design the Endoscopy QBP. He has been a member of numerous colon screening guideline and quality committees at both the provincial and national levels.
11:10 am	What's New in Liver Disease in 2020 Speaker: Dr. Paul Marotta Details Paul Marotta, MD, FRCP(C) Associate Professor University of Western Ontario Transplant Hepatology and Gastroenterology, Medical Director Liver Transplantation, Multiorgan Transplant Unit, London Health Sciences Centre Dr. Marotta has been an academic Hepatologist for over 20 yrs. He completed his Hepatology and Liver Transplant training at the Mayo Clinic in Rochester. He is the Medical Director of Liver Transplantation at the London Health Sciences Centre in London, Ontario as well as being the Program Director of the Advanced Hepatology/Liver Transplantation Fellowship Program. Dr. Marotta is a past president of the Canadian Liver Transplant Network and remains a member of several national and international organizations. Dr. Marotta has extensive publications in peer reviewed journals and remains involved in many clinical research protocols involving early and late phase clinical trials in several therapeutic areas including fatty liver disease (NASH), hepatitis C virus, hepatitis B, hepatocellular malignancy, cost effective analysis, autoimmune liver diseases and immunosuppression in liver transplant population.
11:30 am	What’s New in Upper GI: Pick Your Poison! Speaker: Dr. David Armstrong Details David Armstrong, MA, MB BChir, FRCP (UK), FRCP(C), FACG, AGAF Professor, Division of Gastroenterology & Farncombe Family Digestive Health Research Institute, McMaster University; Consultant Gastroenterologist, Division of Gastroenterology, Hamilton Health Sciences, Hamilton, Ontario, Canada Dr. David Armstrong is Professor of Medicine at McMaster University. His research interests include gastroesophageal reflux disease (GERD), dyspepsia, gastrointestinal (GI) motility, nutrition, short bowel syndrome, colon cancer screening and quality in endoscopy with over 190 peer-reviewed publications, 100 invited reviews and letters and 300 peer-reviewed abstracts. He has been a principal investigator for numerous clinical trials and taken part in many guideline consensus processes related to GERD, Helicobacter pylori, dysphagia, upper GI bleeding, gastroparesis, wireless capsule endoscopy and endoscopy quality. He is Past-President of the Canadian Association of Gastroenterology (CAG), Chair of the Canadian National Colon Cancer Screening Network (NCCSN), Treasurer of the International Working Group on the Classification of Oesophagitis (IWGCO), Vice-Chair of the Guidelines Committee for the World Gastroenterology Organization (WGO) and a Board Member of the Canadian Digestive Health Foundation (CDHF) since 2008.
11:50 am	Panel Discussion Moderator: Dr. David Morgan Details David Morgan, MD, MSc., FRCP(C) Vice President, OAG Head, Service of Gastroenterology St. Joseph's Healthcare, Hamilton Associate Professor, Division of Gastroenterology McMaster University Dr. David Morgan completed his undergraduate training in Human Genetics at McGill University. He did graduate studies including a Masters in Population Genetics. His undergraduate medical studies were completed at McMaster University and Post Graduate studies including Internal Medicine and Gastroenterology, were also completed at McMaster. Dr. Morgan took an additional fellowship year with special attention paid to advanced endoscopic techniques including YAG laser. Dr. Morgan has published on topics such as GI Bleeding, Quality of Life in Cancer Care, Use of Proton Pump Inhibitors and The Prevention of Bleeding from GI Vascular Lesions. Dr. Morgan has participated on several CAG Consensus Panels dealing with such topics as CRC Screening. Dr. Morgan is a member of several international societies, is a Past President of the Canadian Association of Gastroenterology and is the current Vice President of the Ontario Association of Gastroenterology. Dr. Morgan is an Associate Editor for the ACP Journal Club and Evidence Based Medicine and has acted as a reviewer for many journals. Dr. Morgan is on the Faculty at McMaster University and is involved in teaching at the undergraduate and post-graduate levels. He serves on many university and hospital committees. Dr. Morgan is Head of the Service of Gastroenterology and Deputy Chief of Medicine at St. Joseph's Hospital, Hamilton.
12:00 pm	Closing Remarks Speaker: Dr. David Morgan Details David Morgan, MD, MSc., FRCP(C) Vice President, OAG Head, Service of Gastroenterology St. Joseph's Healthcare, Hamilton Associate Professor, Division of Gastroenterology McMaster University Dr. David Morgan completed his undergraduate training in Human Genetics at McGill University. He did graduate studies including a Masters in Population Genetics. His undergraduate medical studies were completed at McMaster University and Post Graduate studies including Internal Medicine and Gastroenterology, were also completed at McMaster. Dr. Morgan took an additional fellowship year with special attention paid to advanced endoscopic techniques including YAG laser. Dr. Morgan has published on topics such as GI Bleeding, Quality of Life in Cancer Care, Use of Proton Pump Inhibitors and The Prevention of Bleeding from GI Vascular Lesions. Dr. Morgan has participated on several CAG Consensus Panels dealing with such topics as CRC Screening. Dr. Morgan is a member of several international societies, is a Past President of the Canadian Association of Gastroenterology and is the current Vice President of the Ontario Association of Gastroenterology. Dr. Morgan is an Associate Editor for the ACP Journal Club and Evidence Based Medicine and has acted as a reviewer for many journals. Dr. Morgan is on the Faculty at McMaster University and is involved in teaching at the undergraduate and post-graduate levels. He serves on many university and hospital committees. Dr. Morgan is Head of the Service of Gastroenterology and Deputy Chief of Medicine at St. Joseph's Hospital, Hamilton.